JAK2 and non-small cell lung carcinoma: While JAK-STAT mutations occur at lower frequencies in solid cancers [159], the JAK2 V617F mutation has also been observed in non-small cell lung cancer (NSCLC), with GOF mutations being linked to alterations in tumor cell PD-L1 [160].